Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 65 composition records across product categories including Specialty occupational products, Laboratory supplies, Cleaning products and household care.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of SUCCINIC ACID in our catalog (epa_cpdat).
Products
65
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 65 composition records across product categories including Specialty occupational products, Laboratory supplies, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including Deodorizer, pH regulating agent, Fragrance.
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 38 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 390 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 60 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 5 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Potency: 0.01 mg/1ml
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 648 mg
US
FDA
FDA NDC lists this ingredient in 17 active drug products and 21 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.